To become a center of excellence that improves the health of patients with chronic diseases in which infection or its immune response plays a major etiologic role.To provide leadership, facilitate multidisciplinary collaboration,
make new discoveries, and educate in the field of infection-associated chronic diseases.
Aim: Our primary aim is to study the roles that infection and the immune response play in the symptoms of patients suffering from chronic, unexplained diseases.
Partial Funding through an educational grant from Pfizer, Inc.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Griffith University ranks in the top five per cent of universities worldwide. It is Australia’s ninth largest higher education provider, with over 43,000 students across five campuses in the Brisbane-Gold Coast region of South-East Queensland, Australia.
The Griffith Health Institute (GHI) is a large, multidisciplinary research institute at Griffith University with a focus on chronic disease prevention and treatments. The Institute conducts research across six programs, investigating the areas of cancer, cardiovascular disease, obesity, musculoskeletal disease, infectious disease, midwifery and family health, positive ageing and mental health. With 650 biomedical scientists and clinical researchers, GHI is producing sustainable improvements in health and well-being. The Institute has had some remarkable research outcomes and achievements recently, supported by high-level local and international collaborations, which foster connectivity, cooperation and accelerate advances. GHI's emphasis on getting results out of the lab and into the hands of clinical professionals is supported by a unique partnership with the nearby Gold Coast University Hospital.
The CFIDS Association envisions a world free of ME/CFS. Our mission is to make ME/CFS understood, diagnosable and treatable. We seek to do this by activating and engaging a community to participate in research in order to accelerate the discovery of safe and effective
treatments while working to aggressively expand funding for treatments and a cure.
Chronic Fatigue Initiative is a science-based 501(c)(3) nonprofit organization fostering and supporting collaboration among the world’s leading medical research, treatment and public health organizations in understanding
the causes, therapies and epidemiology of Chronic Fatigue Syndrome (CFS). Headquartered in New York City and funded by the Hutchins Family Foundation, CFI seeks to accelerate the medical community’s knowledge of CFS through research grants and collaborative processes across institutions.
Hutchins Family Foundation was established by Debbie and Glenn Hutchins to expand research and community initiatives in public policy, education, the environment and public health. Initiatives funded by the Hutchins Family Foundation encourage collaboration among leading public servants, scholars and educators to advance the public good.
is an integrative medicine pharmaceutical company currently pioneering medicines to strengthen immune function and support optimal energy metabolism. We have combined a novel immunomodulator with a currently available medication to produce a treatment for the debilitating fatigue and decreased alertness that commonly afflict people with CFS. The Synergy Trial is a double-blind, placebo-controlled, parallel group study that will enroll 120 participants at four research sites throughout the United States. This trial seeks to confirm positive preliminary findings, expand on the observations made in prior research studies, and further explore the safety and efficacy of this treatment.
ME/CFS Assistant - The ME/CFS assistant is a web site / smart phone application currently in development that collects data from ME/CFS patients to help determine what treatments (Medications, supplements, diets etc.) work and which do not for the individual and the community as a whole, using the strength of crowd sourcing to come up with the answers that the patient and researcher communities need. www.me-cfs.org.
ME Research UK commissions and funds biomedical research into ME/CFS, and provides high quality information on all aspects the of illness for a wide range of audiences. To date, it has awarded more than $1.6 million US to universities in the UK and other countries for 35 distinct scientific studies into ME/CFS, which have resulted in 55 published scientific papers.
Namaste Foods’ great-tasting baking mixes, pasta meals, seasoned coating mixes and new grab and go instant soups are free of gluten, wheat, soy, potato, dairy, casein, peanuts and tree nuts and are carefully manufactured in our 100% dedicated allergen-free facility located in Coeur d’Alene, Idaho. All 23 products are all natural, GFCO certified and free of GMO ingredients.
We want to express that the best part of us wishes you well in every way. In seeking to offer delicious gluten and allergen-free foods, we nourish the body. In nourishing the body, we hope to nourish the mind and the spirit so you can enjoy optimum health.
At Namaste Foods, we meet the needs of more people with food allergies than any other brand! See our website for more information.
New Reality is dedicated to providing a drug free solution for patients dealing with pain and associated sleep issues. The underlying basis for the program is relaxation. While a great concept almost every one agrees it is almost impossible to relax when experiencing excruciating pain. New Reality has developed a technology that couples light frequencies with guided imagery and music to gently guide the listener into the deeply relaxed state of Theta. A natural result of using the New Reality technology to relax the body is that the destructive hormones adrenaline and cortisol are naturally released. Almost everyone feels recharged and rejuvenated in as little as 15 minutes.
In a clinical study conducted by American Pain and Wellness it was reported that all the participants using the New Reality program “slept and average of 6 hours”. Some of the participants had chronic sleep issues for as long as ten years.
Please come and experience this ultimate relaxation for yourself in the Quite Room. We always welcome your comments and input.
Ola Loa produces strategic nutrient drinks that provide Advanced Methylation Support. Our research has shown that under-methylation is a common problem amongst our chronic fatigue and fibromyalgia patients. Methylation is essential for digestion, detoxification, circulation, energy production and immunity. Formulated by Orthomolecular pioneer, Richard Kunin, M.D., Ola Loa has made it easy to get the support your body needs.
Workwell Foundation is a research laboratory that provides disability evaluations for patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) and Fibromyalgia. Our mission is to focus on research concerning the functional aspects of CFS/ME. Our goal is to facilitate an understanding of the biological basis for fatigue and provide objectively determined therapeutic interventions that will improve quality of life for this population. Our unique contribution is educating patients in conjunction with health and fitness professionals.